The MAPK signaling pathway is commonly activated in colon cancers and it has been suggested that all kinases (e.g. RAF, MEK and ERK isoforms) participating in this pathway could be potential targets for therapy15. This evidence concerns the gene MAP2K7 and malignant colon neoplasm.